SF1126 for Patients With Relapsed or Refractory Neuroblastoma
Clinical trial NCT02337309 · TERMINATED
Trial details
- NCT number
- NCT02337309
- Sponsor
- New Approaches to Neuroblastoma Therapy Consortium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2018-05-22
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.